NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner

Kidney International

Volumn 84, Issue 2, 2013, Pages 225-228

  Anders, Hans Joachim ^a   Lech, MacIej ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIGLYCAN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CRYOPYRIN; FIBRINOGEN; HYALURONIC ACID; INFLAMMASOME; MYELOID DIFFERENTIATION FACTOR 88; NEPHRIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; SCLEROPROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULOPATHY; HUMAN; KIDNEY DISEASE; KIDNEY FIBROSIS; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MALE; NEPHRITIS; NOD2 SIGNALING ADAPTOR PROTEIN; PODOCYTES;

EID: 84881158013     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.122     Document Type: Note

References (15)

1. Du P, Fan B, Han H et al. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int 2013; 84: 265-276.
2. Darisipudi MN, Thomasova D, Mulay SR et al. Uromodulin triggers IL-1beta-dependent innate immunity via the NLRP3 inflammasome. J Am Soc Nephrol 2012; 23: 1783-1789.
3. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011; 11: 213-220.
4. Anders HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 2010; 21: 1270-1274.
5. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol 2011; 22: 1007-1018.
6. Migliorini A, Anders HJ. A novel pathogenetic concept-antiviral immunity in lupus nephritis. Nat Rev Nephrol 2012; 8: 183-189.
7. Wu H, Noordmans GA, O'Brien MR et al. Absence of MyD88 signaling induces donorspecific kidney allograft tolerance. J Am Soc Nephrol 2012; 23: 1701-1716.
8. Pulskens WP, Rampanelli E, Teske GJ et al. TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 2010; 21: 1299-1308.
9. Braga TT, Correa-Costa M, Guise YF et al. MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages. Mol Med 2012; 18: 1231-1239.
10. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009; 30: 475-487.
11. Skuginna V, Lech M, Allam R et al. Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. PLoS ONE [online] 2011; 6: e19204.
12. Chowdhury P, Sacks SH, Sheerin NS. Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction. Nephron Exp Nephrol 2010; 115: e122-e130.
13. Campbell MT, Hile KL, Zhang H et al. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res 2011; 168: e61-e69.
14. Vilaysane A, Chun J, Seamone ME et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 2010; 21: 1732-1744.
15. Wang W, Wang X, Chun J et al. Inflammasome-independent NLRP3 augments TGF-beta signaling in kidney epithelium. J Immunol 2013; 190: 1239-1249